Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00125229
Recruitment Status : Terminated (Dr. Hladky died Sept 2006 prior to study completion)
First Posted : July 29, 2005
Last Update Posted : June 26, 2012
Sponsor:
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio

Brief Summary:
This is a clinical study comparing the physiologic effects of two hypertonic solutions (mannitol, hypertonic saline) with a particular emphasis on changes in cerebral blood flow in patients with intracranial hypertension following serious traumatic brain injury (TBI).

Condition or disease Intervention/treatment
Traumatic Brain Injury Intracranial Hypertension Drug: Mannitol Drug: Hypertonic Saline

Detailed Description:
This is a study comparing effects of two hypertonic solutions (mannitol, 6.4% hypertonic saline) on intracranial hypertension, cerebral blood flow, serum/urine osmolarity in patients with increased intracranial pressure caused by traumatic brain injury. The study is conducted during first 72 hours after the injury without any interference with standard medical treatment as performed at the institution. When the hypertonic solution is indicated by caregiver, the study team is informed and performs a set of physiologic bedside measurements including evaluation of cerebral blood flow and changes in plasma and urine osmolarity. The study is noninvasive and the study protocol does not hamper, in any way, standard care of treatment for these patients.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 10 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
Study Start Date : August 2005
Actual Primary Completion Date : June 2006
Actual Study Completion Date : June 2006

Resource links provided by the National Library of Medicine

Drug Information available for: Mannitol





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with severe TBI (motor Glasgow Coma Scale [GCS] score < 5)

  • Age > 18 years
  • Health care provider indicated a treatment of intracranial hypertension using hyperosmotic agent
Criteria

Inclusion Criteria:

  • Patients with severe TBI (motor Glasgow Coma Scale [GCS] score < 5)
  • Age > 18 years
  • Health care provider indicated a treatment of intracranial hypertension using hyperosmotic agent

Exclusion Criteria:

  • Brain dead (GCS 3, fixed dilated pupils)
  • Life-threatening systemic injuries (AIS > 4 in an organ system other than brain); AIS = Abbreviated Injury Score
  • Hypotension not responsive to fluid resuscitation and low doses of dopamine
  • Clinical or imaging sign/suspicion for internal carotid artery injury

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00125229


Locations
Layout table for location information
United States, Texas
Center for Neurosurgery Sciences - UTHSCSA - Surgical Intensive Care Unit (SICU)
San Antonio, Texas, United States, 78229
Sponsors and Collaborators
The University of Texas Health Science Center at San Antonio
Investigators
Layout table for investigator information
Principal Investigator: Roman Hlatky, M.D. Center for Neurosurgical Sciences - UTHSC San Antonio
Publications:

Layout table for additonal information
Responsible Party: The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier: NCT00125229    
Other Study ID Numbers: 045-1503-266
First Posted: July 29, 2005    Key Record Dates
Last Update Posted: June 26, 2012
Last Verified: June 2012
Keywords provided by The University of Texas Health Science Center at San Antonio:
Hypertonic Saline
Mannitol
Intracranial hypertension
Cerebral blood flow
Traumatic brain injury
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Injuries
Brain Injuries, Traumatic
Intracranial Hypertension
Hypertension
Vascular Diseases
Cardiovascular Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries
Mannitol
Diuretics, Osmotic
Diuretics
Natriuretic Agents
Physiological Effects of Drugs